Information for "Manufactured AAV8 capsid receives heparin as well as AVB sepharose joining capacity however offers changed throughout vivo transduction effectiveness"
From EECH Central
Basic information
| Display title | Manufactured AAV8 capsid receives heparin as well as AVB sepharose joining capacity however offers changed throughout vivo transduction effectiveness |
| Default sort key | Manufactured AAV8 capsid receives heparin as well as AVB sepharose joining capacity however offers changed throughout vivo transduction effectiveness |
| Page length (in bytes) | 3,173 |
| Page ID | 1425066 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Forestjudge28 (Talk | contribs) |
| Date of page creation | 07:52, 1 May 2024 |
| Latest editor | Forestjudge28 (Talk | contribs) |
| Date of latest edit | 07:52, 1 May 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
